![Alkylating agents and nucleoside analogues in the treatment of B cell chronic lymphocytic leukemia | Leukemia Alkylating agents and nucleoside analogues in the treatment of B cell chronic lymphocytic leukemia | Leukemia](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fsj.leu.2402531/MediaObjects/41375_2002_Article_BF2402531_Fig1_HTML.gif)
Alkylating agents and nucleoside analogues in the treatment of B cell chronic lymphocytic leukemia | Leukemia
![Randomized comparison of fludarabine, CAP, and ChOP in 938 previously untreated stage B and C chronic lymphocytic leukemia patients - ScienceDirect Randomized comparison of fludarabine, CAP, and ChOP in 938 previously untreated stage B and C chronic lymphocytic leukemia patients - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0006497120569188-gr3.jpg)
Randomized comparison of fludarabine, CAP, and ChOP in 938 previously untreated stage B and C chronic lymphocytic leukemia patients - ScienceDirect
Mantle cell lymphoma in the era of precision medicine-diagnosis, biomarkers and therapeutic agents | Oncotarget
Full article: The role of high-dose corticosteroids in the treatment of chronic lymphocytic leukemia
![PDF) Pediatric Relapsed or Refractory Leukemia: New Pharmacotherapeutic Developments and Future Directions PDF) Pediatric Relapsed or Refractory Leukemia: New Pharmacotherapeutic Developments and Future Directions](https://i1.rgstatic.net/publication/236139753_Pediatric_Relapsed_or_Refractory_Leukemia_New_Pharmacotherapeutic_Developments_and_Future_Directions/links/53d66bc10cf228d363ea55eb/largepreview.png)
PDF) Pediatric Relapsed or Refractory Leukemia: New Pharmacotherapeutic Developments and Future Directions
![Table 1 from Advances in the biology and treatment of B-cell chronic lymphocytic leukemia. | Semantic Scholar Table 1 from Advances in the biology and treatment of B-cell chronic lymphocytic leukemia. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/2185d2faba4ca902d08b7260fd294ee9e7a84cac/4-Table2-1.png)
Table 1 from Advances in the biology and treatment of B-cell chronic lymphocytic leukemia. | Semantic Scholar
![Molecules | Free Full-Text | Current Status of Older and New Purine Nucleoside Analogues in the Treatment of Lymphoproliferative Diseases Molecules | Free Full-Text | Current Status of Older and New Purine Nucleoside Analogues in the Treatment of Lymphoproliferative Diseases](https://pub.mdpi-res.com/molecules/molecules-14-01183/article_deploy/html/images/molecules-14-01183-g001-550.jpg?1535012897)
Molecules | Free Full-Text | Current Status of Older and New Purine Nucleoside Analogues in the Treatment of Lymphoproliferative Diseases
![New agents and regimens for diffuse large B cell lymphoma | Journal of Hematology & Oncology | Full Text New agents and regimens for diffuse large B cell lymphoma | Journal of Hematology & Oncology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13045-020-01011-z/MediaObjects/13045_2020_1011_Fig1_HTML.png)
New agents and regimens for diffuse large B cell lymphoma | Journal of Hematology & Oncology | Full Text
![Cladribine with prednisone versus chlorambucil with prednisone as first-line therapy in chronic lymphocytic leukemia: report of a prospective, randomized, multicenter trial - ScienceDirect Cladribine with prednisone versus chlorambucil with prednisone as first-line therapy in chronic lymphocytic leukemia: report of a prospective, randomized, multicenter trial - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S000649712054305X-gr1.jpg)